Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
0.3810
-0.0090 (-2.31%)
At close: Jun 23, 2026, 4:00 PM EDT
0.3871
+0.0061 (1.60%)
After-hours: Jun 23, 2026, 7:27 PM EDT
Soligenix Employees
As of December 31, 2025, Soligenix had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees decreased by 2 or -12.50% compared to the previous year.
Employees
14
Change (1Y)
-2
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$782,434
Market Cap
5.65M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | -2 | -12.50% | 13 | 1 |
| Dec 31, 2024 | 16 | 1 | 6.67% | 14 | 2 |
| Dec 31, 2023 | 15 | 0 | - | 13 | 2 |
| Dec 31, 2022 | 15 | 0 | - | 13 | 2 |
| Dec 31, 2021 | 15 | -3 | -16.67% | 13 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| BioAtla | 41 |
| CollPlant Biotechnologies | 39 |
| PMGC Holdings | 34 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| Genprex | 13 |
| Processa Pharmaceuticals | 12 |
SNGX News
- 15 days ago - Soligenix to apply for vaccine development funding for Bundibugyo Ebola vaccine - TheFly
- 15 days ago - Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine - PRNewsWire
- 4 weeks ago - Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo - PRNewsWire
- 6 weeks ago - Soligenix reports Q1 EPS (28c) vs. (97c) last year - TheFly
- 6 weeks ago - Soligenix Announces Recent Updates and First Quarter 2026 Financial Results - PRNewsWire
- 6 weeks ago - Soligenix Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Soligenix Earnings release: Q1 2026 - Filings
- 7 weeks ago - Soligenix price target lowered to $1.50 from $10 at Alliance Global - TheFly